Yasmine Wasfi, M.D., Ph.D.

Dr. Wasfi was appointed Chief Medical Officer in October 2025. Prior to that she had served as Savara’s Executive Vice President, Head of Clinical Development and Clinical Operations since July 2024, having previously served as Senior Vice President, Head of Clinical Development. With over two decades of industry and healthcare experience, Dr. Wasfi is a seasoned professional within clinical research and drug development of both large and small molecule novel therapeutics. Her clinical development work includes respiratory drug development and late-phase immunology clinical development. Dr. Wasfi has held roles of increasing responsibility within large pharmaceutical and smaller biotech companies, including Amicus Therapeutics, Johnson & Johnson, and Merck. She received a B.A. in Biology from the University of Delaware, M.D. from the University of Pennsylvania School of Medicine, and Ph.D. in Clinical Science from the University of Colorado Health Sciences Center. She completed her internship and residency in internal medicine at the Hospital of the University of Pennsylvania, and her fellowship in Pulmonary and Critical Care at the University of Colorado Health Sciences Center.